You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 112 No. 6, DECEMBER 1963 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (24)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Secondary Thrombocytopathia

Platelet Factor 3 in Various Disease States

CAPT HARVEY J. WEISS, MC; JAMES W. EICHELBERGER, JR., BS

Arch Intern Med. 1963;112(6):827-834.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The most common platelet disorder which is responsible for abnormal bleeding is thrombocytopenia. In other cases, however, the platelets are normal in number, but appear to be defective in function. Of the many platelet factors, factor 3, or the thromboplastic factor, has been studied most extensively in various conditions. Deficiencies in factor 3 have been reported in uremia, cirrhosis, leukemia, myeloprolif erative disorders, lupus erythematosus, thrombocytopenic purpura, and other disorders. This "qualitative" platelet defect may contribute to the bleeding tendency in these condtions. The results obtained in specific disorders by various investigators have differed,1,2 but the variability no doubt reflects differences in the technique used to measure factor 3. Recently, we have reported the use of a quantitative assay for factor 3, using the thromboplastin generation test (TGT).3 We used a dilute (0.033%) suspension of washed platelets, prepared volumetrically in graduated, thin-stem centrifuge tubes. By this method, we . . . [Full Text PDF of this Article]


Author Affiliations

USAF

Department of Hematology, Walter Reed Army Institute of Research, Washington, DC.


Footnotes

Received for publication June 21, 1963; accepted July 8.

Present address (Dr. Weiss): Department of Medicine, New York University School of Medicine, New York.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1963 American Medical Association. All Rights Reserved.